Home › Huntington's Disease › Tennessee › Nashville
Huntington's Disease clinical trials in Nashville, TN
4 studies for Huntington's Disease are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pridopidine Phase 3 Study in Huntington's Disease
RecruitingPhase 3
- Vanderbilt University Medical Center, Nashville
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
RecruitingPhase 3
- Vanderbilt University Medical CenterX, Nashville
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
RecruitingObservational studyHealthy volunteers welcome
- Vanderbilt University Medical Center, Nashville
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
RecruitingObservational studyHealthy volunteers welcome
- Vanderbilt University Medical Center, Nashville
About Huntington's Disease
Huntington's disease (HD) is an inherited disease that causes nerve cells in the brain to waste away. It causes disability that gets worse over time.
More about Huntington's Disease on MedlinePlus
Huntington's Disease trials in other cities
- Houston, TX5 studies
- New York City, NY4 studies
- Washington, DC4 studies
- Columbus, OH4 studies
- Baltimore, MD4 studies
- Durham, NC4 studies
- Boston, MA4 studies
- Denver, CO4 studies
- Rochester, NY4 studies
- San Diego, CA3 studies
- Burlington, VT3 studies
- Wichita, KS3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.